103 related articles for article (PubMed ID: 18618216)
1. Association of ECRG2 TCA short tandem repeat polymorphism with the risk of oesophageal cancer in a North Indian population.
Jain M; Kumar S; Ghoshal UC; Mittal B
Clin Exp Med; 2008 Jun; 8(2):73-8. PubMed ID: 18618216
[TBL] [Abstract][Full Text] [Related]
2. Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population.
Yue CM; Bi MX; Tan W; Deng DJ; Zhang XY; Guo LP; Lin DX; Lu SH
Int J Cancer; 2004 Jan; 108(2):232-6. PubMed ID: 14639608
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.
Zhang T; Zhao D; Wang Q; Yu X; Cui Y; Guo L; Lu SH
Mol Carcinog; 2013 Aug; 52(8):581-90. PubMed ID: 22315007
[TBL] [Abstract][Full Text] [Related]
4. Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.
Kaifi JT; Cataldegirmen G; Wachowiak R; Schurr PG; Kleinhans H; Kosti G; Yekebas EF; Mann O; Kutup A; Kalinin V; Strate T; Izbicki JR
Anticancer Res; 2007; 27(1A):69-73. PubMed ID: 17352218
[TBL] [Abstract][Full Text] [Related]
5. ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis.
Cui Y; Wang J; Zhang X; Lang R; Bi M; Guo L; Lu SH
Biochem Biophys Res Commun; 2003 Mar; 302(4):904-15. PubMed ID: 12646258
[TBL] [Abstract][Full Text] [Related]
6. Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.
Kaifi JT; Rawnaq T; Schurr PG; Yekebas EF; Mann O; Merkert P; Link BC; Kalinin V; Pantel K; Sauter G; Strate T; Izbicki JR
Am J Surg; 2007 Sep; 194(3):380-4. PubMed ID: 17693286
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of a novel esophageal cancer related gene.
Cui Y; Bi M; Su T; Liu H; Lu SH
Int J Oncol; 2010 Dec; 37(6):1521-8. PubMed ID: 21042721
[TBL] [Abstract][Full Text] [Related]
8. Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.
Blessmann M; Kaifi JT; Schurr PG; Cihan A; Kalinin V; Trump F; Atac A; Heiland M; Pohlenz P; Blake F; Schmelzle R; Izbicki JR
Oral Oncol; 2008 Feb; 44(2):143-7. PubMed ID: 17418617
[TBL] [Abstract][Full Text] [Related]
9. Using yeast two-hybrid system to identify ECRG2 associated proteins and their possible interactions with ECRG2 gene.
Cui YP; Wang JB; Zhang XY; Bi MX; Guo LP; Lu SH
World J Gastroenterol; 2003 Sep; 9(9):1892-6. PubMed ID: 12970870
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with cisplatin.
Song HY; Deng XH; Yuan GY; Hou XF; Zhu ZD; Zhou L; Ren MX
Asian Pac J Cancer Prev; 2014; 15(3):1397-401. PubMed ID: 24606472
[TBL] [Abstract][Full Text] [Related]
11. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
Cheng X; Shen Z; Yang J; Lu SH; Cui Y
J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effects of esophageal cancer related gene 2 on proliferation of human esophageal cancer cell EC9706].
Li MN; Huang G; Guo LP; Lu SH
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2785-8. PubMed ID: 16324322
[TBL] [Abstract][Full Text] [Related]
13. Relationship between esophageal cancer-related gene 2 polymorphism and esophageal squamous cell carcinomas in Kazakhs and Hans of Xinjiang.
Gao L; Li J; Zheng Y
Int J Clin Exp Pathol; 2019; 12(9):3408-3416. PubMed ID: 31934184
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of RNA-binding protein HuR by tumor-suppressor ECRG2.
Lucchesi C; Sheikh MS; Huang Y
Oncogene; 2016 May; 35(20):2565-73. PubMed ID: 26434587
[TBL] [Abstract][Full Text] [Related]
15.
Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
[TBL] [Abstract][Full Text] [Related]
16. ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage.
Patel H; Sheikh MS; Huang Y
Cell Death Dis; 2020 Jul; 11(7):543. PubMed ID: 32681017
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to esophageal cancer-related gene2 protein.
Huang G; Wang D; Guo L; Zhao N; Li Y; Lu SH
Hybridoma (Larchmt); 2005 Apr; 24(2):86-91. PubMed ID: 15857172
[TBL] [Abstract][Full Text] [Related]
18. Mapping the putative binding site for uPA protein in Esophageal Cancer-Related Gene 2 by heteronuclear NMR method.
Geng Y; Feng Y; Xie T; Dai Y; Wang J; Lu SH
Arch Biochem Biophys; 2008 Nov; 479(2):153-7. PubMed ID: 18824154
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hepatocarcinoma model in vitro and in vivo by ECRG2 delivery using adenoviral vector.
Song H; Song C; Wang H; Li C; Yang F; Lu SH; Lin C; Zhan Q; Wang X; Qian H
Cancer Gene Ther; 2012 Dec; 19(12):875-9. PubMed ID: 23079671
[TBL] [Abstract][Full Text] [Related]
20. ECRG2 inhibits cancer cell migration, invasion and metastasis through the down-regulation of uPA/plasmin activity.
Huang G; Hu Z; Li M; Cui Y; Li Y; Guo L; Jiang W; Lu SH
Carcinogenesis; 2007 Nov; 28(11):2274-81. PubMed ID: 17602171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
